In contrast, AKR1B10 expression is low in other tissues, where the enzyme is upregulated in cancers, as well as in non-alcoholic fatty liver disease and several skin diseases. This evidence concerns the gene AKR1B10 and metabolic dysfunction-associated steatotic liver disease.